Publications by authors named "Leland Yee"

Claim this Profile
A
Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B.
Lisa M van Velsen, Lesley A Patmore, Jordan J Feld, Henry L Y Chan, Teerha Piratvisuth, Leland J Yee

Clin Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment.
Grace Lai-Hung Wong, Edward Gane, Calvin Q Pan, Scott Fung, Mang M Ma, Leland J Yee

Aliment Pharmacol Ther· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B Virus Treatment Gaps in the US.
Robert J Wong, Laura E Telep, Charles E Wentworth, Yunhao Liu, Shahed Iqbal, Leland J Yee

JAMA Netw Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir interruption among people with HIV and HBV: HBV monitoring and risk of HBV reactivation and hepatitis flare.
Douglas T Dieterich, Laurence Brunet, Ricky K Hsu, Karam Mounzer, Gerald Pierone, Leland J Yee

AIDS· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching to tenofovir alafenamide in virally-suppressed chronic hepatitis B patients with renal/hepatic impairment: Phase 2 study sub-analysis from Taiwan.
Chun-Jen Liu, Young-Suk Lim, Chi-Yi Chen, Chien-Hung Chen, Yi-Hsiang Huang, Leland J Yee

J Formos Med Assoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral therapy for hepatitis B virus can decrease kidney disease risk.
Kaori L Ito, Yuqing Zhang, Biao Li, Andrew King, Leland J Yee

BMC Nephrol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Viral Load and On-Treatment Hepatocellular Carcinoma Risk in Chronic Hepatitis B: A Multinational Cohort Study.
Won-Mook Choi, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, W Ray Kim, Leland J Yee

Clin Gastroenterol Hepatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase.
Lung-Yi Mak, Leland J Yee, Robert J Wong, Christian B Ramers, Catherine Frenette

J Viral Hepat· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.
Maria Buti, Young-Suk Lim, Henry Lik Yuen Chan, Kosh Agarwal, Patrick Marcellin, Leland J Yee

Aliment Pharmacol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
Won-Mook Choi, Terry Cheuk-Fung Yip, W Ray Kim, Leland J Yee, Craig Brooks-Rooney

Hepatology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B Patients.
Jinlin Hou, Qin Ning, Zhongping Duan, Yu Chen, Qing Xie, Leland J Yee

J Clin Transl Hepatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks.
Scott K Fung, Calvin Q Pan, Grace Lai-Hung Wong, Wai-Kay Seto, Sang Hoon Ahn, Leland J Yee

Aliment Pharmacol Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Young-Suk Lim, Henry L Y Chan, Sang Hoon Ahn, Wai Kay Seto, Qin Ning, Leland J Yee

JHEP Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B.
Young-Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee

Viruses· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.
Won-Mook Choi, Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, W Ray Kim, Leland J Yee

J Hepatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data.
Young-Suk Lim, Wai-Kay Seto, Masayuki Kurosaki, Scott Fung, Jia-Horng Kao, Leland J Yee

Aliment Pharmacol Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study.
Scott Fung, Peter Kwan, Milotka Fabri, Andrzej Horban, Mijomir Pelemis, Leland J Yee

J Hepatol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
W Ray Kim, Thomas Berg, Tarik Asselah, Robert Flisiak, Scott Fung, Leland J Yee

J Hepatol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials.
Tram T Tran, Stuart C Gordon, Scott Fung, Phillip Dinh, Leland Yee

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
W Ray Kim, Rohit Loomba, Thomas Berg, Raul E Aguilar Schall, Leland J Yee

Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years.
Maria Buti, Scott Fung, Edward Gane, Nezam H Afdhal, Robert Flisiak, Leland J Yee

Hepatol Int· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).
Scott Fung, Stuart C Gordon, Zahary Krastev, Andrzej Horban, Jörg Petersen, Leland J Yee

Liver Int· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: To PMID 23813604.
Stuart C Gordon, Eduardo Bruno Martins, Leland J Yee

Hepatology· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load.
Stuart C Gordon, Zahary Krastev, Andrzej Horban, Jörg Petersen, Jan Sperl, Leland J Yee

Hepatology· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the host genetics of chronic hepatitis B and C.
Mark Thursz, Leland Yee, Salim Khakoo

Semin Liver Dis· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis